Lavipharm S.A. (ATH:LAVI)

Lavipharm Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 21, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	265	164	134	134	64	30
Market Cap Growth	95.68%	22.01%	0.36%	107.29%	117.58%	23.40%
Enterprise Value	292	191	157	161	98	66
Last Close Price	1.57	0.97	0.78	0.78	0.37	1.58
PE Ratio	53.70	27.34	14.93	71.42	77.29	17.20
PS Ratio	4.24	2.62	2.53	2.79	1.65	0.75
PB Ratio	4.70	2.90	2.53	3.12	1.60	-2.98
P/TBV Ratio	18.17	11.22	17.21	78.88	-	-
P/FCF Ratio	49.16	30.35	-	-	-	13.52
P/OCF Ratio	39.78	24.56	29.82	470.51	19.27	7.21
EV/Sales Ratio	4.66	3.06	2.96	3.36	2.50	1.67
EV/EBITDA Ratio	21.27	14.81	17.69	19.44	19.70	12.35
EV/EBIT Ratio	33.83	22.18	31.17	34.11	24.01	14.66
EV/FCF Ratio	54.10	35.47	-	-	-	30.17
Debt / Equity Ratio	0.58	0.58	0.64	0.76	0.92	-3.76
Debt / EBITDA Ratio	2.39	2.39	3.53	3.64	6.68	6.28
Debt / FCF Ratio	6.08	6.08	-	-	-	17.03
Net Debt / Equity Ratio	0.47	0.47	0.54	0.56	0.47	-3.59
Net Debt / EBITDA Ratio	2.07	2.07	3.20	2.91	3.82	6.66
Net Debt / FCF Ratio	4.95	4.95	-5.51	-6.39	-0.59	16.28
Asset Turnover	0.49	0.49	0.44	0.42	0.47	0.77
Inventory Turnover	1.49	1.49	1.52	1.93	2.18	2.70
Quick Ratio	0.65	0.65	0.56	0.66	0.70	0.35
Current Ratio	1.21	1.21	1.15	1.27	1.00	0.63
Return on Equity (ROE)	9.23%	9.23%	18.10%	4.74%	6.25%	-
Return on Assets (ROA)	4.22%	4.22%	2.62%	2.57%	3.04%	5.46%
Return on Invested Capital (ROIC)	6.96%	7.06%	6.79%	4.58%	4.02%	11.00%
Return on Capital Employed (ROCE)	10.00%	10.00%	5.80%	6.00%	5.90%	38.60%
Earnings Yield	2.26%	3.66%	6.70%	1.40%	1.29%	5.82%
FCF Yield	2.03%	3.29%	-3.84%	-2.82%	-50.06%	7.40%
Dividend Yield	1.29%	-	2.58%	-	-	-
Payout Ratio	56.48%	56.48%	-	-	-	-
Buyback Yield / Dilution	0.06%	0.06%	-0.17%	-681.40%	-26.42%	-
Total Shareholder Return	1.35%	0.06%	2.40%	-681.40%	-26.42%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.